, tableau récapitulatif des interactions médicaments-plantes médicinales recensées, vol.9

L. and F. , Biotransformations". Pharmacorama : connaissance des médicaments, 0810.

, Variations du métabolisme hépatique des médicaments, 2005.

B. and A. , Les biotransformations des médicaments et des toxiques, vol.2, pp.31-57, 1999.

, Le cytochrome P450 en bref, vol.27, p.197, 2008.

P. , M. , M. , P. , and B. K. , Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mecanism, Clin. Pharmacokinet, vol.31, pp.215-230, 1996.

J. , J. Et, G. , and J. H. , Brussels sprouts and Psychopharmacology : understanding the cytochrome P450 enzyme system, Psychiatr. Clin. North. Am. : Annual of drug therapy, vol.3, pp.205-222, 1996.

M. and Y. Paris, Larousse médical, p.1248, 2003.

C. , K. L. , A. , and S. C. , The cytochrome P450 system : drug interaction principales for medical practice, p.272, 2001.

L. and G. , , 2002.

C. and G. , Interactions alcoolo-médicaments, Nantes : s.n, 2002.

P. and J. , Les oxygénases : enzymes-catalyseurs du monde vivant, Grenoble : Presses Universitaires de Grenoble, collection Grenobles Sciences, pp.819-860, 1995.

L. , J. H. , L. U. , and A. Y. , Inhibition and Induction of Cytochrome P450 and the Clinical Implications, Clin. Pharmacokinet, vol.35, pp.362-390, 1998.

F. and I. , Cytochrome p450 ans vascular homeostasis, vol.89, pp.753-762, 2001.

G. , Y. , M. Ferrari, and L. , Les cytochromes P450 : métabolisme des xénobiotiques, régulation et rôle en clinique, Ann. Biol. Clin, vol.64, pp.535-548, 2006.

L. , J. H. , L. U. , and A. Y. , Interindividual variability in inhibition and induction of cytochromes P450 enzymes, Ann. Rev. Pharmacol. Toxicol, vol.41, pp.533-567, 2001.

M. , O. , G. Brazier, and J. , Intérêt d'un test de mesure de l'activité cytochrome P450 3A in vivo, La Lettre du Pharmacologue, vol.12, pp.6-10, 1998.

, Inhibiteurs et substrats de l'isoenzyme CYP 3A4 du cytochrome P450, La Revue Prescrire, vol.27, p.198, 2008.

M. and U. A. , Pharmacogenetics and adverse drug reactions, Lancet, vol.356, pp.1667-1671, 2000.

F. and T. , The genetic basis of Parkinson's disease, J. Neurol. Neurosurg Psychiatry, vol.73, pp.363-370, 2002.

M. , V. Sellers, T. , and R. F. , Implications of CYP 2D6 genetic variation for smoking behaviors and nicotine dependence, Clin. Pharmacol. Ther, vol.77, pp.145-158, 2005.

M. Watanabe, Polymorphic CYP genes and disease predisposition what have the studies shown so far, Tocicol. Lett, pp.167-171, 1998.

F. , R. J. , L. , K. Et, P. et al., Effects of chargrilled meat diet on expression of CYP 3a, CYP 1A, and P-glycoprotein levels in healthy volunteers, Gastroenterology, vol.117, pp.89-98, 1999.

R. , J. A. , G. , C. , and M. S. , Fetal Hepatic drug elimination, Pharmacol. Ther, vol.84, pp.429-445, 1999.

, Interactions médicamenteuses : le cytochrome P450 en bref, La Revue Prescrire. 2010, vol.30, pp.385-390

M. , V. , T. , and J. , Les cytcotchromes P450 et leur rôle clinique, Le médecin du Québec, vol.37, pp.73-84, 2002.

, Pharmacocinétique clinique : modification de l'exposition plasmatique aux médicaments : mécaninsmes et conséquences cliniques

K. , S. A. , G. Willson, and T. M. , The nuclear pregnane X receptor : a key regulator of xenobiotic metabolism, Endocr. Rev, vol.23, pp.687-702, 2002.

J. Sonoda, R. Xu, and L. U. , A nuclear receptor-mediated response and its implication in drug metabolism and host protection, Curr. Drug. Metab, vol.4, pp.59-72, 2003.

M. , J. M. , S. Cm, and B. Goodwin, Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification, Mol. Pharmacol, vol.62, pp.638-646, 2002.

B. M. Forman, T. Choi, and . Hs, Androstane metabolites bind to and deactivate the nuclear receptor CAR-béta, Nature, vol.395, pp.612-615, 1998.

M. , J. , F. , and Y. , Functionnal role of AhR in the expression of toxic effects of TCDD, Biochim. Biophys. Acta, vol.1619, pp.263-271, 2003.

, Les inducteurs enzymatiques en bref, vol.17, p.200, 2008.

, Petit manuel de Pharmacovigilance et pharmacologie clinique, partie 1 : les inducteurs enzymatiques en bref, La revue Prescrire, p.437, 2011.

A. , C. , and C. Interventionnel, Les inducteurs du cytochrome P450. pharmacies.ma, 2011.

, Interactions médicamenteuses : comprendre et décider : les inducteurs enzymatiques en bref, Le Revue Prescrire. décembre 2010, vol.30, p.390

, Institut des nutraceutiques et des aliments fonctionnels. Pamplemousse et Pomélo. PasseportSanté.net, 2011.

S. and G. , Aliments et médicaments : comment éviter les interactions? s.l, pp.98-100, 2009.

B. and D. G. , Grapefruit juice-drug interactions, Br. Clin. Pharmacol, vol.46, pp.101-110, 1998.

L. and F. , Jus de pamplemousse et médicaments : une association à surveiller, vol.57, pp.432-445, 2002.

A. , Interaction médicaments et jus de pamplemousse-Mise au point". Afsapps.fr, 2008.

B. , D. G. , B. , J. R. Dresser, and G. , Bergamottine, lime juice, and red wine as inhibitor of cytochrome P450 3A4 activity : comparaison with grapefruit juice, Clinical Pharmacology §Therapeutics, vol.73, pp.529-537, 2003.

M. and S. U. , Grapefruit-drug interactions : can interactions with drugs be avoided?, Journal of Clinical Pharmacology, vol.46, pp.1390-1416, 2006.

K. , G. Et, L. , and J. J. , Drug-grapefruit juice interactions, Mayo Clin Proc, vol.75, pp.933-942, 2000.

K. Seden, Grapefruit-drug interactions, Drugs, vol.24, pp.2373-2407, 2010.

B. and D. G. , Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice, Clinical Pharmacology$Therapeutics, vol.81, pp.495-502, 2007.

B. and R. , Exploring mechanisms of this interaction and potential toxicity for certain drugs, Geriatrics, vol.61, pp.12-18, 2006.

L. , K. S. , B. , D. Et, F. et al., Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression, Journal of Clinical Investigation, vol.99, pp.2545-2553, 1997.

T. , H. , O. Matsuo, and H. , Pharmacocinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model, Britsh Jounal of Clinical Pharmacology, vol.49, pp.49-58, 2000.

G. , D. J. , V. Moltke, L. Et, H. et al., Time course of recovery of cytochrome P 450 3A function after single doses of grapefruit juice, Clinical Pharmacology §Therapeutics, vol.74, pp.121-129, 2003.

G. and D. J. , Drug interactions with grapefruit juice : An update, Journal Clinic Psychopharmacology, vol.21, pp.357-359, 2001.

L. and M. , Jus de pamlemousse et médicaments : interactions relatives, 2011.

, Pamplemousse et médicaments : attention!". Extenso.org, 2011.

D. and E. , Grapefruit-drug Interactions : Frequently Asked Questions. PowerNet Design, 2011.

E. Williamson, B. Driver, and K. , Stockley's Herbal Medicines Interactions, Pharma-News. juin, vol.15, pp.6-7, 2004.

L. , J. Et, N. , and M. , effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin, British Journal of Clinical Pharmacology, vol.58, pp.56-60, 2004.

M. Neuman, Effets métaboliques et interactions médicamenteuses provoqués par certaines substances d'origine végétale : pamplemousse, millepertuis, ail, vol.31, pp.1416-1422, 2002.

D. , M. P. , W. , L. Et, E. et al., disposition of intraveinous and oral cyclosporine after administration with grapefruit juice, Clinical Pharmacology$Therapeutics, vol.57, pp.485-491, 1995.

C. , M. , V. Et, M. , and D. , Grapefruit juice-drug interactions : importance for pharmacotherapy, Rev. Med. Chir. Soc. Med. Nat. Iasi, vol.114, pp.885-891, 2010.

A. and V. , Intestinal first metabolism of midazolam in liver cirrhosis-effect of grapefruit juice, British Journal of Clinical Pharmacology, vol.54, pp.120-124, 2002.

H. , C. D. Miron, C. Et, and M. , Flavonoïds-bioactive compouds in fruit juice, Rev. Med.Chir. Soc. Med. Nat. Iasi. Décembre, vol.114, pp.1209-1214, 2010.

M. and S. , Seville orange juice-felodipine interaction : comparison with dilute grapefruit juice and involvement of furanocoumarins, Clinical Pharmacology$Therapeutics, vol.69, pp.14-23, 2001.

G. and L. Q. , Role of furanocoumarin derivates on grapfruit juice-mediated inhibition of human CYP3A activity, vol.28, pp.766-771, 2000.

G. , B. , J. , P. , and B. S. , Potent inhibition of human cytochrome P450 3A4,2D6, and 2C9 isoenzymes by grapefruit juice and its furanocoumarins, Journal Food Sciences, vol.72, pp.417-421, 2007.

, Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins, J. Food. Sci, vol.72, pp.417-421, 2007.

C. , J. Et, B. , and H. , Les interactions médicamenteuses avec le jus de pamplemousse ont elles lieu uniquement avec les préparations commerciales?". Pharmactuel. mai-juin-juillet, vol.39, pp.159-160, 2006.

C. H. Diaconu, C. Et, V. , and L. , Food-drug interactions: grapefruit juice, Re. Med. Chir. Soc. Med. Nat. Iasi, vol.115, pp.245-250, 2011.

, Pas de jus de pamplemousse avec vos médicaments". e-santé.fr, 2011.

R. Tian, K. Et, T. , and H. , Effects of grapefruit juice and orange juice on the intestinal efflux of-Glycoprotein substrates, Pharmaceutical Research, vol.19, pp.802-809, 2002.

A. , , 2011.

, Les interactions médicamenteuses du jus de pamplemousse. Votre pharmacie.be

M. Ohtani, K. Et, K. , and S. , Effect of grapefuit pulp on the pharmacokinetics of the dihydropyridine calcium antagonists nifedipine and nisoldipine, Yakugaku Zasshi, vol.122, pp.323-329, 2002.

P. Odou, F. Et, B. , and C. , Grapefruit juice-nifedipine interaction : possible inolvement of several mechanisms, Journal of Clinical Pharmacy$Therapeutics, vol.30, issue.2, 2005.

S. and D. A. , Interaction of grapefruit juice and calcium channel blockers, Am. J. Hypertens, vol.19, pp.768-773, 2006.

A. , Thésaurus des interaction médicamenteuses. Mise à jour : septembre, 2011.

M. , C. , R. , and R. , Les interactions médicamenteuses, pp.978-980, 2008.

, Guide des interactions médicamenteuses"-Interactions médicamenteuses, Prescrire. Déc, 2011.

M. Schachter, Chemical, pharmacokinetic and pharmacodynamic properties of statins : an update, Fundam Clin Pharmacol, vol.19, pp.117-125, 2005.

E. and I. , Pourquoi faut-il éviter le jus de pamplemousse avec certains médicaments ?". esanté.fr, 2011.

K. and I. , Effects of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese, British Journal of Clinical Pharmacology, vol.57, pp.448-455, 2004.

Y. , H. , F. , H. Kanazawa, and M. , Pharmacological and pharmacokinetic features and clinical effects of pitavastatin, Nippon Yakurigaku Zasshi, vol.123, pp.349-362, 2004.

M. , H. , A. Et, R. , and J. , Intake juice alters the metabolic pattern of cyclosporin A in renal transplant recipients, International Journal of Clinical Pharmacology and Therapeutics, vol.40, pp.451-456, 2001.

P. and M. F. , Further characterization of a furanocoumarin-free grapefruit juice on drug disposition : studies with cyclosporine, Am. J. Clin. Nutr, vol.87, pp.863-871, 2008.

E. , K. , F. Et, O. , and T. , Pomelo-induced in the blood level of tacrolimus in a renal transplant patient, Transplantation, vol.75, p.1057, 2003.

L. and C. , Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients : a prospective study, Eur. J. Clin. Pharmacol, vol.65, pp.881-885, 2009.

B. , D. G. Dresser, and G. K. , Interactions between grapefruit juice and cardiovascular drugs, Am J Cardiovasc Drug, vol.4, pp.281-297, 2004.

B. and K. , Stockley's Drug Interactions. 8th, 2008.

T. Tapaninen, N. Pj, N. , and M. , Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP 3A4 substrate aliskiren, Clinical Pharmacology §Therapeutics, vol.88, pp.339-342, 2010.

D. and M. , Severe overdose in vitamin K antagonist secondary to grapefruit juice absorption, Ann. Fr. Anesth. Reanim. Sept, vol.28, pp.897-899, 2009.

K. Strauch, L. Bittner, and N. , Dose response relationship for interaction grapefruit juice dextromethorphan investigated by human urinary metabolite profiles, Food. Chem. Toxicol, vol.47, pp.1928-1935, 2009.

P. and U. , Grapefruit juice and verapamil : a toxic cocktail, vol.102, pp.308-309, 2009.

T. Okura, Enhancement by grapefruit juice of morphine antinoception, Biol. Pharm. Bull, vol.31, pp.2338-2341, 2008.

P. , T. , K. , and I. , Grapefruit juice interactions with psychotropic drugs : advantages and potential risk, Przegl. Lek, vol.65, pp.92-95, 2008.

A. J. Scheen, Drug-Drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide, Clin. Pharmacokinet, vol.46, pp.93-108, 2007.

A. , Mise au point : Contraception estroprogestative et pamplemousse : que risque t'on vraiment, 2011.

A. and S. , Induction des cytochromes P450 : stress oxydant et susceptibilité

E. Williamson, B. Driver, and K. , Stockley's Herbal Medicines Interactions, p.9780853697602, 2009.

G. , B. J. , G. Sf, and M. A. Hubbard, Cytochrome P450 phenotypic rations for predicting herb-drug interactions in humans, Clin. Pharmacol. Ther, vol.72, pp.276-287, 2002.

T. Zeng, Z. Cl, and . Song, The modulatory effects of garlic oil on hepatic cytochrome P450s in mice, Hum. Exp. Toxicol, vol.28, pp.777-783, 2009.

P. , S. C. , B. , A. H. Et, W. et al., The effect of garlic supplements on the pharmacokinetics of saquinavir, Clin. Inf. Dis, vol.34, pp.234-238, 2002.

G. , K. , F. Et, C. , and S. , Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers, Clin. Pharmacol. Ther, vol.55, pp.199-202, 2003.

J. W. Lampe, K. , L. I. , and S. , Brassica vegetables increase and apiaceous vegetables decrease cytochrom P450 1A2 activity in human : changes in caffeine metabolite ratios in response to controlled diets, vol.21, pp.1157-1162, 2000.

K. and K. E. , Potential interaction between pomegranate juice and warfarin, Pharmacother, vol.29, pp.1002-1006, 2009.

E. , K. , F. Et, and O. , Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient, Transplant, vol.75, p.1057, 2003.

G. , J. , F. , C. Morelli, and G. , Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans, Clin. Pharmacol. Ther, vol.79, pp.255-262, 2006.

T. Velpandian, J. Bhardwaj, and . Rk, Piperine in food : interference in the pharmacokinetics of phenytoin, Eur. J. Drug. Metab Pharmacokinet, vol.26, pp.241-247, 2001.

B. and J. , Dépression et Phytothérapie. Les données de l'évaluation, Tec §Doc, pp.81-96, 2002.

M. and M. , Quality markers of drug information on the internet : an evaluation of sites about St John's wort, Am. J. Med, vol.113, pp.740-745, 2002.

S. Sosa and P. , Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum, J Pharm Pharmacol, vol.59, pp.703-709, 2007.

F. and J. , Les Plantes qui nous soignent, Tradition et thérapeutique, pp.36-37, 2007.

, Le guide des plantes qui soignent, pp.978-980, 2010.

G. and A. , Neuilly-sur-Seine : Michel Lafon, pp.614-616, 2008.

L. , K. Kazanski, and V. , John's xort specifically activates TRPC6 channels, vol.21, pp.4101-4111, 2007.

, Millepertuis : de nombreuses associations à risques, La revue Prescrire, vol.27, p.616, 2007.

B. , V. Hegger, and M. , Flavonoids of St John's wort reduce HPA axis function in the rat, Planta Med, vol.70, pp.1008-1011, 2004.

M. , L. B. , G. Et, and J. Sa, St John's wort induces hepatic drug metabolism through activation of the pregnane X receptor, Proc. Natl. Acad. Sci, vol.97, pp.7500-7502, 2000.

G. , H. , P. , B. , B. Buter et al., Hypericum perforatum : Which constituents may induce intestinal MRD1 and CYP3A4 mRNA expression?, Planta Medica, vol.70, pp.685-690, 2006.

H. Imai, K. Et, T. , and K. , The recovery time-course of CYP3A after induction by StJohn's wort administration, Br. J. Clin. Pharmacol, vol.65, pp.701-707, 2008.

S. Bauer, S. Et, J. , and A. , Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients, Br. J. Clin. Pharmacol, vol.55, pp.203-211, 2003.

G. K. Dresser, U. I. Schwarz, and G. R. Wilkinson, Coordinate induction of both cytochrome P450 3A and MDR1 by St John's wort in healthy subjects, Clinical Pharmacology and Therapeutics, vol.73, pp.41-50, 2003.

H. and M. W. , Effetc of St John's wort administration on CYP2C8 mediated rosiglitazone metabolism, Clinical Pharmacology and Therapeutics, vol.77, p.35, 2005.

W. , Z. , G. , J. C. Hamman, and M. A. , The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity, Clin. Pharmacol. Ther, vol.70, pp.317-326, 2001.

M. , J. S. , D. Devane, and C. L. , Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme, JAMA, vol.290, pp.1500-1504, 2003.

J. S. , M. , D. , C. Et, B. et al., Effect of St John's wort (Hypericum perforatum) on cytochrome P450-2D6 and 3A4 activity in healthy volunteers, Life Sciences, vol.66, pp.133-139, 2000.

O. and R. S. , Inhibition of human cytochromes P450 enzymes by constituents of St John's wort, an herbal preparation used in the treatment of depression, Journal of Pharmacology and Experimental Therapeutics, vol.294, pp.88-95, 2000.

X. , H. Et, K. , and R. B. , St John's wort-associated drug interactions : Short-term inhibition and long-term induction, Clin. Pharmacol. Ther, vol.78, pp.19-24, 2005.

M. Hennessey, K. Spiers, and J. P. , St Jonh's wort increases expression of P-glycoprotein : Implications for drug interactions, Br. J. Clin. Pharmacol, vol.53, pp.75-82, 2002.

D. and M. , Guide des contre-indications des principales plantes médicinales, vol.87260, pp.978-980, 2010.

D. and M. , Possible serotonin syndrome after combination of buspirone and St John's wort, J. Psychopharmacol, vol.16, p.401, 2002.

P. and N. , Interaction millepertuis-venlaflaxine, Press. Méd, vol.29, pp.1285-1286, 2000.

S. , M. Eaton, and L. A. , Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury, Brain. Inj, vol.16, pp.359-367, 2002.

N. Bonneto, S. Et, C. , and A. , Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum, vol.27, pp.1421-1423, 2007.

L. , K. , B. , and M. , Has Hypericum found its place in antidepressant treatment, BMJ, vol.319, p.1539, 1999.

J. , A. Schmider, and J. Brockmoller, Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort (Hypericum perforatum), J. Clin. Psychopharmacol, vol.22, pp.46-54, 2001.

C. , S. , M. , and K. , Delayed emergence and St John's wort, Anesthesiology, vol.96, pp.1025-1027, 2002.

A. , L. , A. Et, A. , and R. , Interaction between a commercially available St John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia, Eur. J. Clin. Pharma, vol.63, pp.913-916, 2007.

S. C. Mueller, M. , J. , U. , and B. , The extent of induction of CYP3A by St John's wort varies among productsand its linked to hyperforin dose, Eur. J. Clin. Pharmacol, vol.62, pp.29-36, 2006.

W. , M. , T. Et, K. , and S. , Effect of St John's wort on the activities of CYP 1A2, CYP 3A4, CYP 2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females, Br. J. Clin. Pharmacol, vol.57, pp.495-499, 2004.

A. , G. , D. Maurer, and A. , No relevant interaction with alprazolam caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract, PLanta. Med, vol.71, pp.331-337, 2005.

A. H. Burstein, . Horton, . Rl, and T. Dunn, Lack of effect of St John's wort on carbamazepine pharmacokinetics in healthy volunteers, Clin. Pharmacol. Ther, vol.68, pp.605-612, 2000.

B. and T. , Profound drop pf cyclosporine A whole blood through levels caused by St John's wort, Transplantation, vol.69, pp.2229-2230, 2000.

A. , D. M. , K. , and U. , Drug interaction of herbal tea containing St John's wort with ciclosporine, Transplant Int, vol.16, pp.543-544, 2003.

W. , M. , T. Et, K. , and S. , Effect of St John's wort on the activities of CYP 1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females, Br. J. Clin. Pharmacol, vol.57, pp.495-499, 2004.

H. , S. D. , W. Huang, and S. , The interaction between St John's wort and oral contraceptive, Clin. Pharmacol. Ther, vol.74, pp.525-535, 2003.

J. and A. , Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum), Clin Pharmacol Ther, vol.66, pp.338-345, 1999.

G. , B. J. Swain, and D. K. Williams, Gauging the clinical significance of P-Glycoproteinmediated herb-drug interactions : Comparative effects of St John's wort, Echinacea, clarithromycin, and rifampicin on digoxin pharmacokinetics, Mol. Nutr. Food. Res, vol.52, pp.772-779, 2008.

, Pfizer Inc. US Prescribing information, 2008.

P. , A. Schiesser, and S. Gerber, Interaction of St John's wort with low-dose oral contraceptive therapy : a randomized controlled trial, Br. J. Clin. Pharmacol, vol.56, pp.683-690, 2003.

R. H. Fogle, M. , P. A. Westhoff, and C. L. , Does St John's wort intefere with the antiandrogenic effect of oral contraceptive pills, Contraception, vol.74, pp.245-248, 2006.

W. and Z. , Effect of St John's wort on the pharmacokinetics of fexofenadine, Clin. Pharmacol. Ther, vol.71, pp.414-420, 2002.

R. Xie, T. Et, and P. Ec, CYP3A and P-glycoprotein activity induction with St John's wort in healthy volunteers from 6 ethnic population, J. Clin. Pharmacol, vol.45, pp.352-356, 2005.

R. F. Frye, F. Sm, . Lagattuta, and . Tf, Effect of St John's wort on imatinib mesylate pharmacokinetics, Clin. Pharmacol. Ther, vol.76, pp.323-329, 2004.

P. and S. C. , Indinavir concentrations and St John's wort, Lancet, vol.355, pp.547-548, 2000.

P. , A. , T. Calvo, and A. , Effects of Hypericum perforatum on ivabradine pharmacokinetics in healthy volunteers : an open-label, pharmacokinetic interaction clinical trial, J. Clin. Pharmacol, vol.46, pp.1188-1194, 2006.

E. Dl, O. , R. , P. Golay, and K. , Methadone maintenance treatement and St John's wort-A case report, Pharmacopsychiatry, vol.36, pp.35-37, 2003.

M. De, Drug interaction between St John's wort and nevirapine, AIDS, vol.15, pp.420-421, 2001.

S. , M. , L. , Z. , and Y. P. , An open trial of nifedipine-herb interactions : nifedipine with St John's wort, ginseng or Ginko biloba, Clin. Pharmacol. Ther, vol.69, p.86, 2001.

W. , X. , L. I. , J. , C. et al., Rapid and simultaneous determination of nifedipine and dehydronifedipine in human plasma by liquid chromotagraphy-tandem mass spectrometry : Application to a clinical herb-drug interaction study, J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci, vol.852, p.534, 2007.

W. , L. , Z. Et, Z. , and B. , St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole, Clin.Pharmacol.Ther, vol.75, pp.191-197, 2004.

N. B. Kumar, A. , B. , and H. , Perioperative herbal supplement use in cancer patients : potential implications nad recommendations for presurgical sreening, Cancer. Control, vol.12, pp.149-157, 2005.

. Ffprhc-guidance, Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit, 2005.

W. , L. Bauer, K. Et, and U. , St John's wort extract does not alter the pharmacokinetics of a low-dose oral contraceptive, Eur. J. Clin. Pharmacol, vol.65, pp.287-294, 2009.

K. Sugimoto, Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin, Clin. Pharm. Ther, vol.70, pp.518-524, 2001.

R. Eggertsen, A. Et, A. , and L. , Effects of treatment with commercially avaible St John's Wort product (Movina) on cholesterol levels in patient with hypercholesterolemia treated with simvastatin, Scand. J. Prim. Health. Care, vol.25, pp.154-159, 2007.

H. , M. F. , P. , C. , and Y. L. , Effects of St John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers, J. Clin. Pharmacol, vol.44, pp.89-94, 2004.

T. Morimoto, K. Et, T. , and K. , Effect of St John's wort on the pharmacokinetics of theophylline in healthy volunteers, J. Clin. Pharmacol, vol.44, pp.95-101, 2004.

C. Tannergren, H. Engman, and L. Knutson, St John's wort decreases the bioavailability of R-and S-verapamil through induction of the first-pass metabolism, Clin. Pharmacol. Ther, vol.75, pp.298-309, 2004.

R. , J. , B. Et, R. , and K. , Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics, Clin. Pharmacol. Ther, vol.78, pp.25-33, 2005.

. Vfend, Pfizer Ltd. UK Summary of product characteristics, 2008.

J. , X. , W. Liauw, and . Ws, Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects, Br. J. Clin. Pharmacol, vol.57, pp.592-599, 2004.

D. , A. Tso, G. , S. , and K. , St John's wort does not interfere with therapeutic drug monitoring of 12 commonly monitored drugs using with immunoassays, J. Clin. Lab. Anal, pp.62-67, 1920.

P. , S. , R. Burk, and M. , Hypertensive crisis associated with St. John's wort, Am. J. Med, vol.112, pp.507-508, 2002.

, Le métabolisme de l'azote-Métabolisme général des acides aminés-Mono-Amine-Oxydase. Faculté médecine, Pierre §Marie Cury-Sorbonne universités

, Interactions et phytothérapie". La revue Prescrire, vol.22, p.669, 2002.

Y. , S. H. , G. , and I. , Analysis of the inhibitory potential of Ginko biloba, Echinacea purpura, and Serenoa repens on the metabolic activity of cytochrome P450 3A4,2D6, and C9, J. Altern. Complement. Med, vol.11, pp.433-439, 2005.

B. H. Hellun, H. U. Et, N. , and O. G. , The induction of CYP 1A2, CYP 2D6, and CYP 3A4 by six trade herbal products in cultured primary human hepatocytes, Basic. Clin. Pharmacol. Toxicol, vol.100, pp.23-30, 2007.

G. and J. C. , The effects of Echinacea (Echinacea purpure root) on cytochrom P450 activity in vivo, Clin. Pharmacol. Ther, vol.75, pp.89-100, 2004.

G. and B. J. , In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes : citrus aurantium, Echinaceae pupurea, milk thistle, and saw palmetto, Clin. Pharmacol. Ther, vol.76, pp.428-440, 2004.

J. W. Budzinski and F. Bc, An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures, Phytomedicine, vol.7, pp.273-282, 2000.

M. , J. Valle, M. , and C. , Herb-drug interaction between Echinacea pupurea and darunavir/ritonavir in HIV-infected patients, Antimicrob Agents Chemother, vol.55, pp.326-330, 2011.

P. , S. R. , R. Sm, and . Hunt, Echninacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjects, Pharmacotherapy, vol.30, pp.797-805, 2010.

J. Barnes, A. , L. A. Et, P. , and J. D. , Herbal Medecines, p.721, 2007.

D. , J. L. , D. Cl, . Chavin, and . Kd, Siberian Ginseng (Eleutherococcus senticosus) : effects on CYP 2D6 and CYP 3A4 Activity in Normal Volunteers, Drug Metab. Dispos, vol.31, pp.519-522, 2003.

H. , M. R. , H. Gl, and L. Zhou, Effects of Siberian ginseng (Eleutherococcus senticosus) on c-DNA-expressed P450 drug metabolizing enzymes, Alt. Ther, vol.7, pp.7-14, 2001.

T. and T. , Effects of Acanthopanax senticosus HARMS extract on drug transport in human intestinal cell line Caco-2, J. Nat. Med, vol.64, pp.55-62, 2010.

S. Mcrae, Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng, CMAJ, vol.155, pp.293-295, 1996.

A. and D. , Siberian ginseng toxicity may be case of mistaken identity (letter), CMAJ, vol.155, p.1237, 1996.

Y. , O. Q. Tomlinson, W. Et, and . Mm, Pharmacogenetics and herb-drug interactions : experience with Ginkgo biloba and omeprazole, Pharmacogenetics, vol.14, pp.841-850, 2004.

H. , B. H. , N. , and O. G. , In vitro inhibition of CYP3A4 metabolism and P-glycoprotein mediated transport by trade products, Basic Clin. Pharmacol. Toxicol, vol.102, pp.466-475, 2008.

F. , L. , M. Xq, and G. Y. Tao, Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of tanilol in healthy volunteers, Xenobiotica, vol.39, pp.249-254, 2009.

G. and A. S. , Ginkgo biloba precipitating epileptic seizures, vol.30, pp.523-525, 2001.

K. , T. , R. , and V. , Fatal seizures due to potential herb-drug interactions with Ginkgo biloba, J. Anal. Toxicol, vol.29, pp.755-758, 2005.

M. , H. , I. Tanaka, and S. , Generalized convulsions after consuming a large amount of ginkgo nuts, Epilepsia, vol.42, pp.280-281, 2001.

K. , Y. , K. Tanaka, and N. , Pretreatment with Ginkgo biloba extract weakens the hypnosis action of phenobarbital and its plasma concentration in rats, J. Pharm. Pharmacol, vol.56, pp.401-405, 2004.

N. Ohnishi, K. Et, Y. , and M. , Studies on interactions between functionnal foods or dietary supplements and medicines. Effects of Ginkgo biloba leaf on the pharmacokinetics of diltiazem in rats, Biol. Pharm. Bull, vol.26, pp.1315-1320, 2003.

S. , M. , L. , Z. , and Y. P. , An open trial of nifedipine-herb interactions : nifedipine with St. John's wort, ginseng or Ginko biloba<, Clin. Pharmacol. Ther, vol.69, p.86, 2001.

Y. , M. , O. Et, K. , and T. , Studies on interactions between functionnal foods or dietary supplements and medicines. Effetcs of Ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of niffedipine in healthy volunteers, Biol. Pharm. Bull, vol.27, pp.2006-2009, 2004.

K. , Y. , K. Tanaka, and N. , Interaction of Ginkgo biloba extract (GBE) with hypotensive agent, nicardipine, in rats, vol.17, pp.409-412, 2003.

S. M. Robertson, D. Voell, and J. , Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects, Curr. Med. Res. Opin, vol.24, pp.591-599, 2008.

A. A. Izzo, E. , and E. , Interactions between herbal medicines and prescribed drugs : an updated systemic review, Drugs, vol.69, pp.1777-1798, 2009.

C. , T. , C. Benetton, and S. A. , In vitro effect standardiezd ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP 1A2 and CYP1B1, Drug. Metab. Dispos, vol.30, pp.378-384, 2002.

A. S. Etheridge, . Black, P. Sr, and P. R. , An in vivo evaluation of cytochrome P450 inhibition and Pglycoprotein interaction with Goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents, PLanta. Med, vol.73, pp.731-741, 2007.

Y. and C. S. , Brief communication : American ginseng reduces warfarin's effect in healthy patients : a randomized, Ann. Intern. Med, vol.141, pp.23-27, 2004.

R. and M. F. , Thrombosis of a prosthetic aortic valve disclosing a hazardous interaction between warfarin and a commercial ginseng product, Cardiology, vol.99, p.111, 2003.

L. , Y. H. , L. Bk, and Y. J. Choi, Interaction between warfarine and korean reg ginseng in patient with cardiac valve replacement, Int. J. Cardiol, 2009.

L. , S. H. , A. Ym, . Ahn, and . Sy, Interaction between warfarin and panax ginseng in ischemic stroke patient, J. Altern. Complement Med, vol.14, pp.715-721, 2008.

H. , H. Tang, G. O. Et, and V. L. , Hypoglycemic herbs and their action mechanisms, Chin. Med, vol.4, p.11, 2009.

N. I. , H. X. , Y. U. , Y. , and X. H. , The study of ginsenoside on PPARgamma expression of mononuclear macrophage in type2 diabetes, Mol. biol. Rep, vol.37, pp.2975-2979, 2010.

K. , K. , P. , Y. Kim, and H. , Ginsenoside Rg3 Suppresses Palmitate-Induced Apoptosis in MN6N8 Pancreatic beta Cells, J. Clin. Biochem. Nutr, vol.46, pp.30-35, 2010.

C. , G. , M. Et, H. , and P. , Interaction of licorice on glycyrrhizin pharmacokinetics. Environ Health Prespect, vol.102, pp.65-69, 1994.

P. , M. , P. Sapone, and A. , Effect of licorice and glycyrrhizin on murine liver CYPdependent monooxygenases, Life. Sci, vol.62, pp.571-582, 1998.

L. and D. , Investigation on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo, Clin. Pharmacol. Ther, vol.69, pp.356-364, 2001.

S. Zhou, L. Ly, C. , and B. , herbal modulation of P-glycoprotein, Drug. Metab. Rev, vol.36, issue.1, pp.57-104, 2004.

U. , C. , B. Et, W. , and W. , An evidence-based systematic review of herb and supplement interactions by the Natural Standard Research Collaboration, Expert Open Drug Saf, vol.5, pp.719-728, 2006.

U. Svensson, A. , H. , and T. N. , Artemisinin induces omeprazole metabolism in human beings, Clin. Pharmacol. Ther, vol.64, pp.160-167, 1998.

C. , J. A. , H. , A. G. Ramos, and S. I. , Effects of caffeine withdrawal from the diet on the metabolism of clozapin in schizophrenic patients, J. Clin. Psychopharmacol, vol.18, pp.311-316, 1998.

X. Wu, L. I. Xin, and H. , Effects of berberine on the blood concentration of ciclosporine A in renal transplanted recipients : clinical and pharmacokinetic study, Eur. J. Clin. Pharmacol, vol.61, pp.567-572, 2009.

R. L. Nahin, . Barnes, . Pm, . Stussman, and . Bj, Costs of Complementary and Alternative Medicine (CMA) and Frequency of Visits to CAM Practitioners : United States, Natl. Health. Stat Reports, vol.18, pp.1-14, 2007.

L. Prescrire and . Guide, Eviter les effets indésirables par interactions médicamenteuses, comprendre et décider, p.326, 2010.

S. and M. , Motivations for consulting complementary and alternative medicine, BMC Complement Altern, vol.8, p.16, 2008.

A. , G. Boon, and H. , CAM in Canada: places, practices, research, Complementary Therapies in Clinical Practice, vol.11, pp.21-27, 2005.

D. Z. Samdup, S. Song, and S. , The use of complementary and alternative medicine in children with chronic medical conditions, Am. J. Phys. Med. Rehabil, vol.85, pp.842-846, 2006.

P. M. Barnes, . Bloom, and R. L. Nahin, Complementary and alternative medicine use among adults and children : United States, Natl. Health. Stat. Reports, vol.12, pp.1-23, 2007.

E. and E. , Noncompliance with conventionnal medicine and use of complementary/alternative medicine, J. Postgrad, vol.53, p.85, 2007.

J. Vm, B. Sharmaet, and N. , Study of association between use of complementary and alternative medicine and non-compliance with modern medicine in patients presenting to ermegency department, J. Postgrad. Med, vol.53, pp.96-101

Z. , S. Benowitz, and N. L. , Drug interactions with tobacco smoking : an update, Clin. Pharmacokinet, vol.36, issue.6, pp.425-438, 1999.

S. Zevin, G. Sg, B. , and N. L. , Clinical pharmacology of nicotine, Clin. Dermatol, vol.16, pp.557-564, 1998.

D. Hoffmann, E. Hoffmann, and K. , The less harmful cigarette : a controversial issue. A tribute to Ernest L. Wynder, Chem. Res. Toxicol, vol.14, pp.767-790, 2001.

D. , G. W. Vestal, and R. F. , Smoking and drug metabolism, Pharmacol. Ther, vol.15, pp.207-221, 1981.

. Van-vleet, B. Tr, C. Dw, and R. A. , Inhibition of human cytochrome P450 2E1 by nicotine, cotinine, and aqueous cigarette tar extract in vitro, Toxicol. Sci, vol.64, pp.185-191, 2001.

C. and A. C. , Sensitivy to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion, J. Pharmacol. Exp. Ther, vol.271, pp.125-133, 1994.

C. and B. J. , Cigarette smoking and theophylline metabolism, Clin. Pharmacol. Ther, vol.37, pp.330-336, 1985.

M. and P. R. , Effect of passive smoking on theophylline clearance in children, Therapeutic Drug Monitoring, vol.23, pp.503-505, 2001.

S. and J. R. , Cigarette smoking and clinically significant drug interactions, Ann. Pharmacother, vol.29, pp.1139-1148, 1995.

, Influence du tabac sur l'activité et la cinétique des médicaments, MANEN, M. Marseille : s.n, 1994.

G. and M. J. , Effects of tabacco smoking and oral contraceptive use on theophylline disposition, Br. J. Clin. Pharmacol, vol.16, pp.271-280, 1993.

G. , J. J. Birkett, and D. J. , Cigarette smoking and theophylline clearance and metabolism, Clin. Pharmacol. Ther, vol.30, pp.491-496, 1981.

R. K. Salokangas, S. Taiminen, and T. , Effect of smoking on neuroleptics in schizophrenia, Schizophr. Res, vol.23, pp.55-60, 1997.

S. , G. I. , F. , and I. , Chlorpromazine plasma levels, adverse effects, and tabacco smoking : a case report, J. Clin. Psychiatry, vol.44, pp.420-422, 1993.

M. Hasegawa, G. , R. , and W. , Relationship between clinical efficacity and clozapine concentrationsin plasma in schizophrenia effect of smoking, J. Clin. Psychopharmacol, vol.13, pp.383-390, 1993.

N. H. Seppala, L. , E. V. Et, L. , and M. L. , Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients, Pharmacol.Toxicol, vol.85, pp.244-246, 1999.

P. , P. J. , B. , K. A. Arndt, and S. , Relationship between patient variables and plasma clozapine concentrations : a dosing nomogram, Biol. Psychiatry, vol.44, pp.733-738, 1998.

P. and T. I. , Interactions between the cytochrome P450 system and the second-generationantipsychotics, 2003.

L. and D. E. , A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tabacco smoking behaviors, 2005.

S. , R. B. , G. Pr, W. , and C. E. , Single-and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men, Clin. Pharm, vol.2, pp.139-143, 1983.

D. , H. , S. Et, J. , and M. , Smoking in patients receiving psychotropic medications : a pharmacokinetic perspective, CNS Drugs, vol.15, pp.469-494, 2001.

S. and O. , Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans, Clin. Pharmacol. Ther, vol.58, pp.399-403, 1995.

H. and J. R. , Antidepressants for smoking cessation, 2004.

M. Ishida, O. Kaneko, and S. , Effects of various factors on steady state plasma concentration of trazodone and its active metaboliste m-chlorophenylpiperazine, Int. Clin. Psychopharmacol, vol.10, pp.143-146, 1995.

H. , P. H. , S. Giargiari, and . Td, Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers, J. Clin. Pharmacol, vol.37, pp.737-743, 1997.

F. R. Buhler, Impact of smoking on heart atacks, strockes, blood pressure control, drug dose, and quality of life aspects in the Internaional Prospective Primary Prevention Study in Hypertension, Am. Heart. J, vol.115, pp.282-288, 1988.

P. Bolli, . Buhler, and J. K. Mckenzie, Smoking antihypertensive treatment benefit, and comprehensive antihypertensive treatment approach : some thoughts on the results of the International Prospective Primary Prevention Study in Hypertension, J. Cardiovasc. Pharmacol, issue.7, pp.77-80, 1990.

G. , M. , B. Et, P. , and N. , Tabac et médicaments : liaisons dangereuses?". Alcoologie et addictologie, vol.23, pp.7-12, 2001.

G. and O. , Effect of cigarette smoking on mexiletine kinetics, Clin. Pharmacol. Ther, vol.37, pp.638-643, 1985.

M. , N. , F. Eto, and K. , Effects of cigarette smoke inhalation on plasma diltiazem levels in rats, Methods Find Exp. Clin. Pharmacol, vol.19, pp.173-179, 1997.

D. , J. , W. Et, K. , and S. , Cigarette smoking and the treatment of angina with propranolol, atenolol and nifedipine, N. Engl. J. Med, vol.310, pp.951-954, 1984.

D. Kang, V. , and K. Me, Population analyses of sustained-release verapamil in patients : effects of sex, race, and smoking, Clin. Pharmacol. Ther, vol.73, pp.31-40, 2003.

F. , U. , M. , H. Kern, and R. , Effects of grapefruit juice and smoking on verapamil concentrations in steady state, Eur. J. Clin Pharmacol, vol.58, pp.45-53, 2002.

Z. and S. , Cardiovascular effects of carbon monoxide and cigarette smoking, Am. J. Col. Cardiol, vol.38, pp.1633-1638, 2001.

M. and J. J. , Increased 2-hydroxylation of estradiol as o possible mechanismfor the antiestrogenic effect of cigarette smoking, N. Engl. J. Med, vol.315, pp.1305-1309, 1986.

W. , S. , W. Sm, and P. F. Coville, Cigarette smoking enhances the elimination of quinine, Br. J. Clin. Pharmacol, vol.36, pp.610-614, 1993.

C. R. Brown, Changes in rate and pattern of caffeine metabolism after cigarette abstinence, Clin. Pharmacol. Ther, vol.43, pp.488-491, 1988.

B. , N. L. , J. , and P. , Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism, Clin. Pharmacol. Ther, vol.67, pp.653-659, 2000.

M. , S. Hoffmann, T. Et, and R. F. , Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment, Biochem. Pharmacol, vol.15, pp.1501-1511, 2000.

K. and L. A. , Drug interactions with smoking, 2007.

N. and R. , Coffee, cigarettes and meds : what are the metabolic effects?, 2005.

E. and C. B. , Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP 1A2 gene, 2004.

. Wikipédia, , 2012.

J. and J. , , pp.26-36

M. , A. , P. , E. , A. et al., Interactions alcool-xénobiotiques. Rôle du cytochrome P450 2E1, Pathol. Biol, vol.49, pp.696-702, 2001.

G. , C. , H. Et, T. , and T. , Tocicité de l'éthanol". s.l. : Encyclopédie méd. Chir., ToxicitéPathologie professionnelle, pp.1-8, 1995.

P. , F. , P. Et, P. , and P. , Alcoolisation aigüe et médicaments, pp.2075-2080

E. , A. Sgro, and C. , alcool et médicament : mélange détonnant". Le médecin généraliste FMC, pp.9-11, 1756.

V. S. , , 2011.

J. and C. , Horaires, alimentation et médicament, Cahier du Moniteur des pharmacies. 2005, vol.2563, pp.1-16, 2564.

C. Berr, C. , and F. Dally, Alcool : effets sur la santé" Chap. 14, Interactions entre alcool et médicaments, pp.267-275, 2001.

E. and D. , Interactions alcool-médicaments, Thérapie, vol.50, pp.199-202, 1995.

T. and M. , Médicaments, alcool, tabac, J. Pharm. Clin, vol.11, pp.23-27, 1992.

J. L. Saulnier, Interactions entre alimentation et les médicaments, J. Pharm. Clin, vol.11, pp.20-22, 1992.

C. , N. , C. , and J. , Gérer les interactions : alcool et médicaments". Cahier conseil du Moniteur des pharmacies, pp.35-37, 1998.

T. and S. , Alcool et médicaments". Thèse pour le diplôle d'état de docteur en pharmacie. Nantes : s.n, 1999.

B. and J. , Interactions entre alcool et les médicaments". Thèse pour le diplôme d'état de docteur en pharmacie. Tours : s.n, p.5, 1996.

L. and W. M. , Drug-induced hepatotoxicity, N. Engl. J. Med, vol.349, pp.474-485, 2003.

L. , A. , B. , J. Et, D. et al., La mésaventure thérapeutique du paracétamol chez le buveur excessif, Gastroentérol. Clin. Biol, vol.30, pp.769-774, 2006.

D. , P. , D. , H. Cox, and C. , Alcohol-acetaminophen syndrome.Even moderate social drinkers are at risk, Postgrad. Med, vol.107, pp.189-195, 2000.

P. and L. F. , Paracetamol, alcohol and the liver, Br. J. Clin. Pharmacol, vol.49, pp.291-301, 2000.

L. E. Schmidt, D. Poulsen, and H. E. , Acute versus chronic alcohol consumption in acetaminophen-induced hepatotxicity, Hepatology, vol.35, pp.876-882, 2002.

G. Vendemiale, A. Et, L. , and C. S. , Altered biliary excretion of acetaminophen in rats fed ethanol chronically, Drug Metab Dispos, vol.12, pp.20-24, 1984.

W. , R. M. , M. , T. E. , M. C. Elligott et al., Acetaminophen toxicity in fed and fasted mice, Can J Physiol Pharmacol, vol.60, pp.399-404, 1982.

A. , I. , L. Et-rundgren, and M. , Zonaction of acetaminophen metabolism and cytochrome P4502E1-mediated toxicity studied in isolated periportal and perivenous hepatocytes, Biochem Pharmacol, vol.45, pp.1251-1259, 1993.

Z. , P. , S. , and J. T. , Effects of ethanol withdrawal on rat liver mitochondrial glutathione : implication of potentiated acetaminophen toxicity in alcoholics, Drug Metab Dispos, vol.30, pp.1413-1417, 2002.

J. T. Slattery, N. Sd, T. , and K. E. , The complex interaction between ethanol and acetaminophen, Clin. Pharmacol. Ther, vol.60, pp.241-246, 1996.

P. Zhao, K. , S. , and J. T. , Selective mitochondrial glutathione depletion by ethanol enhances acetaminophen toxicity in rat liver, Hepatology, vol.36, pp.326-335, 2002.

K. , H. , B. Bu, Y. , and M. , CYP2E1 is not involved in early alcohol-induced liver injury, Am. J. Physiol, p.277, 1999.

L. , J. M. , C. , G. , and C. , Acetalehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress, Gastroenterology, vol.124, pp.708-724, 2003.

T. , K. E. Slattery, and N. Sd, Effect of ethanol o hepatotoxicity of acetaminophen in mice and on reactive metabolite formation by mouse and human liver microsomes, Toxicol. Appl. Pharmacol, vol.100, pp.391-397, 1989.

T. , K. E. , S. Ro, and H. , Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults, Clin. Pharmacol. Ther, vol.67, pp.591-599, 2000.

C. , J. A. Benitez, and J. , Clinically significant pharmacokinetic interactions between dietary caffeine and medications, Clin. Pharmacokinet, vol.39, pp.127-153, 2000.

, Caféine-provenance, vol.14, 2009.

P. Smits, . Schouten, T. Et, and T. , Cardiovascular effects of two xanthines and the relation to adenosine antagonism, Clin. Pharmacol. Ther, vol.45, pp.593-599, 1989.

M. and J. , Time for abstention from caffeine before an adenosine myocardial perfusion scan, Nuvl. Med. Commun, vol.21, pp.361-364, 2000.

J. , J. , S. , F. Sauter, and R. , The influence of caffeine on the steady-state pharmacokinetics of theophylline, Clin. Pharmacol. Ther, vol.49, pp.248-255, 1991.

J. Sato, N. , H. Owada, and E. , Influence of usual intake of dietary caffeine on single-dose of theophylline in healthy human subjects, Eur. J. Clin. Pharmacol, vol.44, pp.295-298, 1993.

R. , K. , R. Et, L. , and J. , Effetc of caffeine-containing versus decaffeinated coffee on serum clozapine concentration in hospitalised patients, Basic. Clin. Pharmacol. Toxicol, vol.94, pp.13-18, 2004.

H. , S. , S. Et, M. , and T. , Effect of caffeine on clozapine pharmacokinetics in healthy volunteers, Br. J. Clin. Pharmacol, vol.49, pp.59-63, 2000.

O. Leon and J. , Clozapine levels and caffeine, J. Clin Psychiatry, vol.57, pp.175-176, 1996.

, Centre d'informations thérapeutiques et de pharmacovigilance, 2011.

N. , S. Saussays, and C. , Les interactions entre plantes et médicaments, 2011.

S. Gaël, Aliments et médicaments : comments éviter les interactions? s.l, pp.98-100, 2009.

K. , G. Et, L. , and J. J. , drug-grapefruit juice interactions, Mayo Clin Proc, vol.75, pp.933-942, 2000.

G. and D. J. , Drug interactions with grapefruit juice : An update, Jouranl Clinic Psychopharlacology, vol.21, pp.357-359, 2001.

L. and C. , Co-administration of grapefruit juice incereases bioavailability of tacrolimus in liver transplant patients : a prospective study, Eur. J. Clin. Pharmacol, vol.65, pp.881-885, 2009.

L. , F. , E. , and E. , Botanical Products-Drugs Interactions : Focus on Garlic, Ginko and Ginseng, pp.108-112, 2006.

Y. , O. Tomlinson, W. Et, and M. , Pharmacogenetics and herb-drug interactions : experience with Ginki biloba and omeprazole, pp.841-850

H. S. Niu, L. Im, and J. T. Cheng, Hypoglycemic effect of syringin from Eleutherococcus senticosus in streptozotocin-induced rats, Planta Med, vol.74, pp.109-113, 2008.

K. Watanabe, K. Sato, and J. , Fundamental studies on the inhibitory action of Acanthopanax senticosus Harms on glucose absorption, J. Ethnopharmacol, vol.131, pp.193-199, 2010.

X. , S. H. , F. , and D. C. , Pharmacological action and mecanisms of ginkgolid B, Clin. Med. J, vol.120, pp.922-928, 2007.

L. Fontana, . Souza, and E. A. Bel, Ginkgo biloba leaf extract (EGb 761) enhances catalepsy induced by haloperidol and L-nitroarginine in mice, Braz. J. Med. Biol. Ress, vol.38, pp.1649-1654, 2005.

J. , Y. R. , and Y. U. Lee, Antithrombotic and antiplatelet activities of Korean red ginseng extract, Basic. Clin. Pharmacol. Toxicol, vol.100, pp.170-175, 2007.

H. A. Sigurjonsdottir, M. Et, A. , and M. , Subjects with essential hypertension are more sensitive to the inhibition of 11 béta-HSD by liquorice, J. Hum. Hypertens, vol.17, pp.125-131, 2003.

J. , A. Van, and W. H. Hoefnagels, The old lady who liked liquorice : hypertension due to chronic intoxication in a memory-impaired patient;3, Neth. J. Med, vol.63, pp.149-150, 2005.

M. , S. C. , A. , R. , and P. M. , Too muchof a good thing : a woman with hypertension and hypokalemia, Clin. Chem, vol.55, pp.2093-2096, 2009.

Y. , H. , A. , H. Sendur, and M. A. , Brugada syndrome with aborted sudden cardiac death related to liquorice-induced hypokalemia, Med. Princ. Pract, vol.19, pp.485-489, 2010.

A. Mauer, Interaction of St John's wort extract with phenprocoumon, Eur.J.Clin.Pharmacol, vol.55, p.22, 1999.

M. , M. , H. Rmw, and R. Mathot, Drug interaction between St John's wort and nevirapine, AIDS, vol.15, pp.420-421, 2001.

R. Mathijssen, V. Brunijn, and P. , Effects of St John's wort on irinotecan metabolism, J. Nat. Cancer Inst, vol.94, pp.1247-1249, 2002.

R. , J. , B. Et, R. , and K. , Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics, Clin. Pharmacol. Ther, vol.78, pp.25-33, 2005.

S. , , vol.22, p.8, 2011.

S. Bauer, S. Et, K. , and H. , Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients, Br. J. Clin. Pharmacol, vol.55, pp.203-211, 2003.

G. , V. V. Sherma, and . Nk, Hormonal effects of smoking : effects on plasma renin activity, Am. J. Med. Sci, vol.291, pp.321-324, 1986.

O. and E. , Effect of smoking on serum concentrations of total homocysteine, folate, vitamine B12 and nitric oxide in pregnancy : a preliminary study, Fetal. Diagn. Ther, vol.19, pp.145-148, 2004.

M. and S. D. , Folate levels in pregnant women who smoke : an important gene/environment interaction, An. J. Obset. Gynecol, vol.187, pp.620-625, 2002.

E. , D. , B. , and N. , Les interactions alcool-médicaments : mécanismes et conséquences pratiques, J. Pharm. Clin, vol.15, pp.91-98, 1996.

D. and P. H. , Guide partiques des interactions médicamenteuses. s.l. : Maloine, 2009.

B. F. Sands, K. , C. Et, C. , and D. A. , Interaction of alcohol with therapeutic drugs and drugs of abuse". Handbook of experimental pharmacology, pp.475-512, 1995.

. Adenoscan-(adénosine, Summary of product characteristics, 2005.

J. and J. E. , Critical review of dietary caffeine and blood pressure : a relationship thate should be taken more seriously, Psychosom. Med, vol.66, pp.63-71, 2004.

N. , M. , U. Cs, and A. Lr, Blood pressure response to chronic intake of coffee and caffeine : a meta-analysis of randomized controlled trials, J. Hypertens, vol.23, pp.921-928, 2005.

T. and A. , Effect of caffeine on the bioavailability and pharmacokinetics of aspirin, J. Med. Assoc. Thai, vol.72, pp.562-566, 1989.

Z. , W. Y. Pro, and A. , Do codeine and caffeine enhance the analgesic effect of aspirin : a systemic overview, J. Clin. Pharm. Ther, vol.22, pp.79-97, 1997.

M. , M. E. , M. , N. , and E. , Caffeine moderately antagonizes the effects of triazolam and zopiclone on the psychomotor performance of healthy subjects, Pharmacol. Toxicol, vol.70, pp.286-289, 1992.

C. , R. M. , F. Et, H. , and J. S. , Pharmacokinetic and pharmacodynamic interactions betwwen zolpidem and caffeine, Clin. Pharmacol. Ther, vol.82, pp.54-62, 2007.

P. Smits, Dose-dependent inhibition of the hemodynamic response to dipyramidole by caffeine, Clin. Pharmacol. Ther, vol.50, pp.529-537, 1991.

M. , R. , T. Et, and M. , Caffeine withdrawal increases lithium blood levels, Biol. Psychiatry, vol.37, pp.348-350, 1995.

J. and J. W. , Lithium tremor and caffeine intake : two cases of drinking less and shaking more, J. Clin. Psychiatry, vol.49, pp.72-73, 1988.

J. , A. Buemann, and S. Toubro, The appetite-suppressant effect of nicotine in enhanced by caffeine, Diabetes Obes. Metab, vol.7, pp.327-333, 2005.

K. A. Perkins, F. , C. Stolinski, and A. , The influence of caffeine on nicotine's discriminative stimulus, subjective, and reinforcing effects, Exp. Clin. Pharmacol, vol.13, pp.275-281, 2005.

R. , B. , C. Et, G. , and T. , Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen, J. Clin. Pharmacol, vol.47, pp.715-726, 2007.